These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 3998028)

  • 1. High-performance liquid chromatographic method for quantitative determination of Yutac, a new antiarrhythmic agent, in dog plasma.
    Rónai-Lukács S; Kozma M; Vereczkey L
    J Chromatogr; 1985 Mar; 338(2):428-32. PubMed ID: 3998028
    [No Abstract]   [Full Text] [Related]  

  • 2. High-performance liquid chromatographic determination of BRB-I-28, a novel antiarrhythmic agent, in dog plasma and urine.
    Chen CL; Lesseley BA; Clarke CR; Roder JD; Sangiah S; Berlin KD; Garrison GL; Scherlag BJ; Lazzara R; Patterson E
    J Chromatogr; 1992 Dec; 583(2):274-9. PubMed ID: 1478994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of bisaramil and its metabolite in plasma using high-performance liquid chromatography with electrochemical detection.
    Matsushima E; Sato T
    J Chromatogr; 1992 Jan; 573(2):339-44. PubMed ID: 1601972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiarrhythmic effects of bisaramil in canine models of ventricular arrhythmia.
    Haruno A; Hashimoto K
    Eur J Pharmacol; 1993 Mar; 233(1):1-6. PubMed ID: 8472737
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and plasma protein binding of the new potent class III antiarrhythmic agent 3-[4-(1H-imidazol-1-yl)benzoyl]-7-isopropyl-3, 7-diazabicyclo[3.3.1]nonane dihydroperchlorate.
    Chen CL; Sangiah S; Roder JD; Chen H; Berlin KD; Garrison GL; Scherlag BJ; Lazzara R
    Arzneimittelforschung; 1995 Jun; 45(6):670-5. PubMed ID: 7646568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic study of bisaramil in man.
    Gémesi L; Kapás M; Matos L
    Acta Pharm Hung; 1993 Nov; 63(6):327-33. PubMed ID: 8116453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological activity of the metabolites of syn-3-ethyl-7-methyl-3,7-diazabicyclo[3.3.1]non-9-yl 4-chlorobenzoate hydrochloride.
    Yamawaki I; Bukovac SW; Sunami A
    Chem Pharm Bull (Tokyo); 1994 Nov; 42(11):2365-9. PubMed ID: 7859336
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Medical management of arrhythmias; newer antiarrhythmic drugs].
    Yamashita T; Sugimoto T
    Nihon Rinsho; 1991 Nov; 49(11):2680-6. PubMed ID: 1685198
    [No Abstract]   [Full Text] [Related]  

  • 9. Determination in plasma of a new antiepileptic drug, dl-(5 alpha,9 alpha,11S*)-5,6,9,10-tetrahydro-N,N-dimethyl-5,9-methanobenzocycloo cten-11-amine hydrochloride, and its N-desmethyl metabolite by liquid-solid extraction and capillary gas chromatography.
    Yonekawa WD; Kapetanovic IM; Kupferberg HJ; Paanakker JE; van de Laar GL
    J Chromatogr; 1986 Apr; 377():205-12. PubMed ID: 3711209
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparative study of the antiarrhythmic properties of eicosanoid inhibitors, free radical scavengers and potassium channel blockers on reperfusion induced arrhythmias in the rat.
    Beatch GN; Courtice ID; Salari H
    Proc West Pharmacol Soc; 1989; 32():285-9. PubMed ID: 2780604
    [No Abstract]   [Full Text] [Related]  

  • 11. Single ion monitoring assay for the serotonin re-uptake blocker Org 6582 in plasma.
    Vink J; van Hal HJ; van de Laar GL
    Biomed Mass Spectrom; 1982 Sep; 9(9):370-5. PubMed ID: 7139056
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further studies into the ECG effects of tedisamil (KC 8857) in rats.
    Howard PG; Abraham S; Courtice ID; Walker MJ
    Proc West Pharmacol Soc; 1989; 32():183. PubMed ID: 2780585
    [No Abstract]   [Full Text] [Related]  

  • 13. A high-performance liquid chromatographic method for the determination of stobadin pharmacokinetics in serum.
    Soltés L; Kállay Z; Bezek S; Fedelesová V
    Biopharm Drug Dispos; 1991; 12(1):29-35. PubMed ID: 2039810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pilotropic activity of silatranes].
    Voronkov MG; Bakhareva EV; Kuznetsov IG
    Dokl Akad Nauk SSSR; 1982; 262(3):736-9. PubMed ID: 7060453
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypocholesterolemic action of 1-ethoxysilatrane.
    Mehta PP; Ramasarma T; Kurup CK
    Biochim Biophys Acta; 1987 Jul; 920(1):102-4. PubMed ID: 3593753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of 2-[N-[(S)-1-ethoxycarbonyl-3-phenylpropyl]-L-alanyl]-(1S,3S,5S)-2- azabicyclo[3.3.0]octane-3-carboxylic acid (Hoe 498) and its hydrolysis product in serum and urine.
    Hajdú P; Schmidt D; Bomm M; Hack L; Keller A
    Arzneimittelforschung; 1984; 34(10B):1431-5. PubMed ID: 6097270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Clinical evaluation of a new spasmolytic: sintropium bromide (VAL 480) in spastic states of the upper and lower urinary tract].
    Colosi V; Arcidiacono G; Mignosa E; Biraghi M
    Minerva Urol Nefrol; 1986; 38(3):271-8. PubMed ID: 3810389
    [No Abstract]   [Full Text] [Related]  

  • 18. Maternal plasma bicycling PGE2 levels following vaginal administration of prostaglandin E2 pessaries in full term pregnancies.
    McLaren M; Greer IA; Smith JR; Godfree V; Graham N; Calder AA
    Prog Clin Biol Res; 1987; 242():199-203. PubMed ID: 3478732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [HPLC determination of diprafenone and its active metabolite 5-hydroxydiprafenone in human plasma].
    Zhong D; Blume H
    Pharmazie; 1994 Jan; 49(1):38-41. PubMed ID: 8140128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RG 12915: a potent 5-hydroxytryptamine-3 antagonist that is an orally effective inhibitor of cytotoxic drug-induced emesis in the ferret and dog.
    Fitzpatrick LR; Lambert RM; Pendley CE; Martin GE; Bostwick JS; Gessner GW; Airey JE; Youssefyeh RD; Pendleton RG; Decktor DL
    J Pharmacol Exp Ther; 1990 Aug; 254(2):450-5. PubMed ID: 2166791
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.